USP33 anticorps (C-Term) (FITC)

N° du produit ABIN7174318

Détail du produit anti-USP33 anticorps (FITC)

Antigène: USP33 (Ubiquitin Specific Peptidase 33 (USP33))

Épitope: AA 251-550, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp USP33 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Ubiquitin carboxyl-terminal hydrolase 33 protein (251-550AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur USP33

Antigène: USP33 (Ubiquitin Specific Peptidase 33 (USP33))

Autre désignation: USP33 (USP33 Produits)

Synonymes: anticorps USP33, anticorps VDU1, anticorps 9830169D19Rik, anticorps AA409780, anticorps Vdu1, anticorps zgc:77308, anticorps ubiquitin specific peptidase 33, anticorps universal stress protein UspA, anticorps Usp33, anticorps USP33, anticorps RR_RS17870, anticorps usp33

Sujet:

Background: Deubiquitinating enzyme involved in various processes such as centrosome duplication, cellular migration and beta-2 adrenergic receptor/ADRB2 recycling. Involved in regulation of centrosome duplication by mediating deubiquitination of CCP110 in S and G2/M phase, leading to stabilize CCP110 during the period which centrioles duplicate and elongate. Involved in cell migration via its interaction with intracellular domain of ROBO1, leading to regulate the Slit signaling. Plays a role in commissural axon guidance cross the ventral midline of the neural tube in a Slit-dependent manner, possibly by mediating the deubiquitination of ROBO1. Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination of beta-arrestins (ARRB1 and ARRB2) and beta-2 adrenergic receptor (ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta-arrestins, leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Mediates deubiquitination of both \'Lys-48\'- and \'Lys-63\'-linked polyubiquitin chains.

Aliases: Deubiquitinating enzyme 33 antibody, EC 3 1 2 15 antibody, hVDU1 antibody, KIAA1097 antibody, MGC16868 antibody, OTTHUMP00000011234 antibody, OTTHUMP00000011330 antibody, OTTHUMP00000011331 antibody, pVHL interacting deubiquitinating enzyme 1 antibody, Ubiquitin carboxyl terminal hydrolase 33 antibody, Ubiquitin carboxyl-terminal hydrolase 33 antibody, Ubiquitin specific peptidase 33 antibody, Ubiquitin specific processing protease 33 antibody, ubiquitin specific protease 33 antibody, Ubiquitin thioesterase 33 antibody, Ubiquitin thiolesterase 33 antibody, Ubiquitin-specific-processing protease 33 antibody, UBP33_HUMAN antibody, USP 33 antibody, Usp33 antibody, VDU 1 antibody, VDU1 antibody, VHL interacting deubiquitinating enzyme 1 antibody, VHL-interacting deubiquitinating enzyme 1 antibody

UniProt: Q8TEY7

Pathways: Regulation of G-Protein Coupled Receptor Protein Signaling